Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Psychiatry/Psychology | Neurology | Family Medicine
 Disease Category: Depression
Location: United States, CA

Trial Information

A Double-Blind, Placebo-Controlled, Fixed-Dose Study of Vilazodone in Patients with Major Depressive Disorder

To further characterize the efficacy, safety and tolerability of a single fixed dose level of velazodone (40 mg) relative to placebo in patients with moderate to severe major depressive disorder (MDD).

Patient Inclusion Criteria:

  • Male or Female; 18-70 years of age; Body Mass Index between 18-40; negative urine drug screen; have normal physical examination findings; normal clinical laboratory and ECG results. Female of childbearing potential must have negative pregnancy screen.

Patient Exclusion Criteria:

  • Positive drug screen; clinically significant concurrent medical history; woman who are pregnant, planning to become pregnant or breast feeding.

Barbara Katz, RN, CCRC, Study Coordinator
Pharmacology Research Institute, Newport Beach
1601 Dove Street, Suite 290
Newport Beach, CA 92660
Phone: 949-752-7936
Fax: 949-752-1412
Email: newport@priresearch.com

View Map

Research Center Information: Pharmacology Research Institute, Newport Beach

If you would like to learn more about participating in this study, please send an email message using the form below.

Name:
Address:
City:
State:
Country:
Phone:
Email:  
Message:
 

DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.